The biggest health story today is a food safety failure unfolding in real time. A record-breaking Cyclospora outbreak has now claimed two lives in Michigan, and the Trump administration reportedly knew about the deaths but delayed public reporting. The parasite, linked to contaminated produce, has also triggered recalls at Taco Bell and Chipotle, with Bloomberg reporting that Taco Bell met with Michigan officials weeks before its recall. The Ars Technica report on the delayed notification is damning, and the Bloomberg coverage of the fatalities underscores how rare and serious this is. Cyclosporiasis deaths are extremely unusual, so two in a single outbreak signals something has gone badly wrong with food safety oversight. The Chipotle connection shows this is not a niche concern; it is hitting major national chains. Beyond the outbreak, the system is showing cracks elsewhere. A TIME investigation into the chemotherapy drug shortage highlights how a market failure for generics like cisplatin and carboplatin is forcing rationing for up to 20% of cancer patients. Meanwhile, states are pushing back against new federal Affordable Care Act coverage provisions, and the Axios report on Medicaid work requirements suggests a looming eligibility fight that could strip coverage from the most vulnerable. These are not separate stories; they are symptoms of a healthcare infrastructure that is being squeezed from every angle, from supply chains to policy. On the lifestyle front, the data is shifting. A new study shows marijuana use has surpassed cigarettes in the US, with 43.8 million regular users versus 36.1 million smokers. And while GLP-1 drugs are celebrated for weight loss, a HuffPost piece on hair loss is catching patients off guard. The broader trend here is that Americans are changing their habits faster than the public health system can track them, and the side effects of our new choices are only beginning to surface.